title: Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
abstract: BACKGROUND
  In facilitating informed decision making about PSA screening, men are often asked to consider the potential consequences of the test, including a diagnosis of prostate cancer and how they would want to be treated. However, there is no empirical evidence thus far demonstrating that men are able to consider this hypothetical situation in a realistic manner.
  
  
  OBJECTIVE
  To compare the features (attributes) of treatments that are important to non-patient men considering a hypothetical diagnosis of prostate cancer with those deemed important to men actually diagnosed with early-stage disease.
  
  
  METHODS
  Two groups of men went through a decision aid interview to help them choose between treatment options for early-stage prostate cancer: non-patient men who imagined themselves to be diagnosed with the disease, and newly diagnosed patients. During the interview participants identified features of the treatment and disease that were important to their decisions.
  
  
  RESULTS
  The percentage of non-patients and patients that thought particular attributes were important was correlated: r (33) = 0.77, p < 0.01. The effects on bladder and bowel functioning were considered important to >or=50% of each group. In addition to the 22 attributes initially presented, 49% of non-patients and 67% of patients identified additional attributes as being important to their decision. Eight (42%) of the 19 additional attributes were identified by non-patients and patients alike.
  
  
  CONCLUSIONS
  The group of non-patient men provided a close approximation to the group of newly diagnosed men with respect to the attributes identified as being important to their treatment decisions for early-stage prostate cancer, suggesting that the consideration of what is important to the decision by non-patient men is realistic.
authors.affiliation: Kingston General Hospital, 76 Stuart Street, Kingston, ON, Canada K7L 2V7. lori.vanmanen@krcc.on.ca
authors.forename: Lori
authors.initials: L
authors.lastname: Van Manen
authors.forename: Deb
authors.initials: D
authors.lastname: Feldman-Stewart
authors.forename: Michael D
authors.initials: MD
authors.lastname: Brundage
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003657:Decision Making; D003661:Decision Support Techniques; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D010358:Patient Participation; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000523:psychology* / Q000628:therapy*
chemical_list: D017430:Prostate-Specific Antigen